Skip to content

A multicenter comparative study of clinical diagnosis and treatment modalities for renal tuberculosis

A multicenter comparative study of clinical diagnosis and treatment modalities for renal tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087965
Enrollment
Unknown
Registered
2024-08-08
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal tuberculosis

Interventions

Typical clinical symptom groups: =3 clinical symptoms(Frequent urination, urgency, pain in urination, difficulty in urination, back pain, fever, night sweats):None
Atypical clinical symptom groups: <3 clinical symptoms(Frequent urination, urgency, pain in urination, difficulty in urination, back pain, fever, night sweat:None

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: They were included in the study if at least one of the following criteria was met: 1) renal tuberculosis was clearly diagnosed by pathologic findings; 2) treatment with anti-tuberculosis drugs was effective; and 3) renal tuberculosis was diagnosed by a combination of clinical manifestations, laboratory tests, and imaging.

Exclusion criteria

Exclusion criteria: Patients were excluded from this study if one of the following conditions was met: 1) pathological findings did not support the diagnosis of renal tuberculosis; 2) patient diagnostic and treatment data were missing; 3) patients with concomitant urological malignancies; 4) patients with severe impairment of renal function limited to dialysis in hospitals; and 5) renal tuberculosis was a non-primary diagnosis, with other serious urological diseases.

Design outcomes

Primary

MeasureTime frame
Anti-tuberculosis drug therapy cure rate;Ureteral stenting cure rate;Nephrectomy rate;Nephrectomy cure rate;

Secondary

MeasureTime frame
Clinical symptom;

Countries

China

Contacts

Public ContactPanfeng Shang

Lanzhou University Second Hospital

220220905651@lzu.edu.cn+86 181 4376 1248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026